Patients, providers, manufacturers, and pharmacies are typically in agreement that when prescribed a specialty medication, starting a patient on that therapy should be a top priority. Unfortunately, ...

The success of well-developed protocols has been limited in real-world practice, where even effective strategies have not been sufficient to meet patient needs in routine clinical care owing to Axis I ...